These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 9418970)

  • 21. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy.
    Höftberger R; Kunze M; Weinhofer I; Aboul-Enein F; Voigtländer T; Oezen I; Amann G; Bernheimer H; Budka H; Berger J
    Neurobiol Dis; 2007 Nov; 28(2):165-74. PubMed ID: 17761426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral inflammation in X-linked adrenoleukodystrophy.
    McGuinness MC; Smith KD
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):281-7. PubMed ID: 10604233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.
    McGuinness MC; Lu JF; Zhang HP; Dong GX; Heinzer AK; Watkins PA; Powers J; Smith KD
    Mol Cell Biol; 2003 Jan; 23(2):744-53. PubMed ID: 12509471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
    Singh J; Khan M; Singh I
    J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.
    Corzo D; Gibson W; Johnson K; Mitchell G; LePage G; Cox GF; Casey R; Zeiss C; Tyson H; Cutting GR; Raymond GV; Smith KD; Watkins PA; Moser AB; Moser HW; Steinberg SJ
    Am J Hum Genet; 2002 Jun; 70(6):1520-31. PubMed ID: 11992258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
    Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
    Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
    Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.
    Berger J; Gärtner J
    Biochim Biophys Acta; 2006 Dec; 1763(12):1721-32. PubMed ID: 16949688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterization of the adrenoleukodystrophy protein (ALDP) and disease pathogenesis.
    Gärtner J; Dehmel T; Klusmann A; Roerig P
    Endocr Res; 2002 Nov; 28(4):741-8. PubMed ID: 12530690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening for carrier and prenatal diagnosis of X-linked adrenoleukodystrophy].
    Wang AH; Bao XH; Xiong H; Pan H; Wu Y; Zhang YH; Shi CY; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):345-9. PubMed ID: 15924749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
    Kemp S; Wanders RJ
    Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic variability in a Tunisian family with X-linked adrenoleukodystrophy caused by the p.Gln316Pro novel mutation.
    Kallabi F; Ellouz E; Tabebi M; Ben Salah G; Kaabechi N; Keskes L; Triki C; Kamoun H
    Clin Chim Acta; 2016 Jan; 453():141-6. PubMed ID: 26686776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
    Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
    Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases.
    Jia Z; Pei Z; Li Y; Wei L; Smith KD; Watkins PA
    Mol Genet Metab; 2004; 83(1-2):117-27. PubMed ID: 15464426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical aspects of X-linked adrenoleukodystrophy.
    Kemp S; Wanders R
    Brain Pathol; 2010 Jul; 20(4):831-7. PubMed ID: 20626744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.
    Kemp S; Wei HM; Lu JF; Braiterman LT; McGuinness MC; Moser AB; Watkins PA; Smith KD
    Nat Med; 1998 Nov; 4(11):1261-8. PubMed ID: 9809549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy.
    Pujol A; Ferrer I; Camps C; Metzger E; Hindelang C; Callizot N; Ruiz M; Pàmpols T; Giròs M; Mandel JL
    Hum Mol Genet; 2004 Dec; 13(23):2997-3006. PubMed ID: 15489218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency.
    Oezen I; Rossmanith W; Forss-Petter S; Kemp S; Voigtländer T; Moser-Thier K; Wanders RJ; Bittner RE; Berger J
    Hum Mol Genet; 2005 May; 14(9):1127-37. PubMed ID: 15772093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters.
    Liu LX; Janvier K; Berteaux-Lecellier V; Cartier N; Benarous R; Aubourg P
    J Biol Chem; 1999 Nov; 274(46):32738-43. PubMed ID: 10551832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy.
    Boehm CD; Cutting GR; Lachtermacher MB; Moser HW; Chong SS
    Mol Genet Metab; 1999 Feb; 66(2):128-36. PubMed ID: 10068516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.